Brad Hively

Director, Starling Oncology, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.0M

Companies

Latest trade

Aug 21, 2026

Companies

Starling Oncology, Inc.Director −$2.0M

Trades

STLN Sold 298,853 shares at $6.51 · planned $1.9M Aug 21

STLN Sold 13,333 shares at $3.77 $0.1M Dec 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.